Report | A Third of COVID-19 mRNA Vaccinated Individuals Suffered Sudden Death | Six Million Six Hundred and Seventy-Seven Thousand Deaths Reported in the U.S.

Report | A Third of COVID-19 mRNA Vaccinated Individuals Suffered Sudden Death | Six Million Six Hundred and Seventy-Seven Thousand Deaths Reported in the U.S.

In a recent study, researchers from the German-Jordanian University and the University of Petra have delved into the effects of COVID-19 vaccines on vaccinated individuals. The study, titled "MERCK, MODERNA, PFIZER/BioNTech, and JANSSEN COVID-19 vaccines on vaccinated people: A metadata analysis," was published in the journal Informatics in Medicine Unlocked.

1. Mortality Rate
2. The analysis found that deaths following COVID-19 mRNA vaccination (Moderna and Pfizer/BioNTech) were relatively rare events compared to the total number of vaccinated individuals.
3. Mortality rates associated with Janssen (Johnson & Johnson) and Merck vaccines varied due to differences in vaccine rollout and population coverage.
4. Demographics
5. Elderly populations and those with preexisting comorbidities showed higher rates of adverse outcomes, including death, after vaccination, reflecting their greater baseline vulnerability rather than a direct causal link to the vaccine.
6. No strong evidence indicated increased mortality among younger, healthy individuals tied directly to the vaccines.
7. Timing of Deaths
8. Most deaths reported in association with the vaccines occurred within the first few weeks post-vaccination, often within 7 to 21 days.
9. The timing is consistent with the window for related adverse effects such as myocarditis or thrombotic events but also overlaps with natural mortality in high-risk groups.
10. Symptoms
11. The study documented 40 different symptoms among the vaccinated population, with headache, chills, and fatigue being the most common.
12. Age Group
13. The majority of deaths occurred among individuals under the age of 60.
14. Overall Conclusion
15. The metadata analysis supports the safety profile of COVID-19 mRNA vaccines, indicating that while some deaths occur temporally after vaccination, causality is not established broadly.
16. The vaccines remain effective and safe for the vast majority of recipients, especially when considering their benefits in preventing severe COVID-19 outcomes that carry higher mortality risks.

The World Council for Health, an organisation advocating for a better way, has suggested that the findings of this study should trigger a moratorium on the Covid gene therapy trial. However, it is crucial to note that the study does not definitively prove a causal link between the vaccines and the reported deaths or symptoms.

For more detailed statistical values or subgroups analysed, please refer to the original study.

1. Compared to the total number of vaccinated individuals, deaths following COVID-19 mRNA vaccination (Moderna and Pfizer/BioNTech) were relatively uncommon events, and the reverse was found for Janssen (Johnson & Johnson) and Merck vaccines due to differences in vaccine rollout and population coverage.
2. The study's documentation of 40 different symptoms among the vaccinated population highlighted headache, chills, and fatigue as the most common symptoms.
3. Most deaths reported in association with the vaccines occurred within the first few weeks post-vaccination, often within 7 to 21 days, and while this timing overlaps with natural mortality in high-risk groups, it is consistent with the window for related adverse effects such as myocarditis or thrombotic events.

Read also: